Journey Medical Corp
DERM· Nasdaq
Released Aug 8, 2023, after the close
10-Q filed Aug 10, 2023, 41 days after period end · 0001410578-23-001702
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $16.96M | $18.24M | $15.29M |
| Net Income | -$8.36M | -$7.53M | -$11.87M |
| EPS Diluted | -$0.46 | -$0.43 | -$1.30 |
Journey Medical Corp · CIK 1867066 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.